Invention Grant
- Patent Title: Antibody binding to chondroitin sulfate proteoglycan 5
-
Application No.: US17255692Application Date: 2019-06-26
-
Publication No.: US11965035B2Publication Date: 2024-04-23
- Inventor: Nobuaki Takahashi , Ryosuke Nakano , Sayaka Maeda , Yuji Ito
- Applicant: Kyowa Kirin Co., Ltd. , KAGOSHIMA UNIVERSITY
- Applicant Address: JP Tokyo
- Assignee: KYOWA KIRIN CO., LTD.,KAGOSHIMA UNIVERSITY
- Current Assignee: KYOWA KIRIN CO., LTD.,KAGOSHIMA UNIVERSITY
- Current Assignee Address: JP Tokyo; JP Kagoshima
- Agency: WENDEROTH, LIND & PONACK, L.L.P.
- Priority: JP 18120476 2018.06.26
- International Application: PCT/JP2019/025450 2019.06.26
- International Announcement: WO2020/004490A 2020.01.02
- Date entered country: 2020-12-23
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C12N5/16 ; G01N33/50

Abstract:
The invention relates to an antibody which binds to chondroitin sulfate proteoglycan 5 (CSPG5) or an antibody fragment thereof, a hybridoma which produces the antibody or the antibody fragment thereof, a nucleic acid comprising a nucleotide sequence encoding the antibody or the antibody fragment thereof, a transformant cell comprising a vector comprising the nucleic acid, a method for producing the antibody or the antibody fragment thereof, a composition comprising the antibody or the antibody fragment thereof, and a method for detecting or measuring an antigen present in the brain, a method for diagnosing or treating a brain disease, a method for enhancing the property of accumulating in a brain of an antibody, and a method for increasing the amount of an antibody in the brain, each of which using the antibody or the antibody fragment thereof, and the like.
Public/Granted literature
- US20210269548A1 ANTIBODY BINDING TO CHONDROITIN SULFATE PROTEOGLYCAN 5 Public/Granted day:2021-09-02
Information query